Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Astria Therapeutics, Inc. - Common Stock
(NQ:
ATXS
)
13.14
+0.21 (+1.62%)
Streaming Delayed Price
Updated: 11:03 AM EST, Jan 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Astria Therapeutics, Inc. - Common Stock
< Previous
1
2
Next >
Astria Therapeutics Inc (NASDAQ:ATXS) Reports Q3 2025 Earnings Miss, Focus Remains on Pending Acquisition and Pipeline
↗
November 12, 2025
Astria Therapeutics missed Q3 2025 earnings and revenue estimates, but the stock's focus remains on its promising HAE drug pipeline and the pending acquisition by BioCryst.
Via
Chartmill
Topics
Earnings
Unusual volume stocks in Monday's session
↗
October 20, 2025
In today's session, these stocks are experiencing unusual volume.
Via
Chartmill
This Verisk Analytics Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday
↗
October 16, 2025
Via
Benzinga
BioCryst Stock Tumbles On Astria Buyout, But Analysts Stay Bullish — Retail Cheers The Move As Long-Term Play
↗
October 14, 2025
Via
Stocktwits
Dow Jumps Over 300 Points; Citigroup Posts Upbeat Earnings
↗
October 14, 2025
Via
Benzinga
Topics
Stocks
BioCryst To Acquire Astria Therapeutics In $700M Deal
↗
October 14, 2025
Via
Stocktwits
Earnings Preview For Astria Therapeutics
↗
November 10, 2023
Via
Benzinga
Expert Ratings for Astria Therapeutics
↗
October 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
October 14, 2025
Via
Benzinga
BioCryst Says Astria Therapeutics $700 Million Deal Gives 'Perfect Second Product Candidate'
↗
October 14, 2025
BioCryst will acquire Astria Therapeutics for $700 million to expand its HAE portfolio with navenibart, aiming for double-digit revenue growth.
Via
Benzinga
Which stocks are gapping on Tuesday?
↗
October 14, 2025
Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via
Chartmill
Domino's Pizza Posts Upbeat Results, Joins Astria Therapeutics, Albertsons Companies, Polaris And Other Big Stocks Moving Higher On Tuesday
↗
October 14, 2025
Via
Benzinga
Which stocks are moving before the opening bell on Tuesday?
↗
October 14, 2025
As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
October 14, 2025
Via
Benzinga
Astria Therapeutics Inc (NASDAQ:ATXS) Reports Narrower-Than-Expected Q2 2025 Loss and Strong Cash Runway
↗
August 12, 2025
Astria Therapeutics reports Q2 2025 results with a narrower-than-expected loss, extended cash runway, and progress in clinical trials for navenibart and STAR-0310.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
June 13, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
December 24, 2024
Via
Benzinga
Limoneira And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
December 24, 2024
Via
Benzinga
Arm Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
December 23, 2024
Via
Benzinga
Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket
↗
December 23, 2024
Shares of Rumble Inc.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
November 14, 2024
Via
Benzinga
ATXS Stock Earnings: Astria Therapeutics Misses EPS for Q2 2024
↗
August 12, 2024
ATXS stock results show that Astria Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
ATXS Stock Earnings: Astria Therapeutics Misses EPS for Q1 2024
↗
May 09, 2024
ATXS stock results show that Astria Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
March 20, 2024
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and...
Via
Benzinga
ATXS Stock Earnings: Astria Therapeutics Misses EPS for Q4 2023
↗
March 04, 2024
ATXS stock results show that Astria Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
January 25, 2024
Via
Benzinga
$5.6M Bet On This Real Estate Stock? Check Out These 3 Stocks Insiders Are Buying
↗
December 26, 2023
Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for Astria Therapeutics: Here's What You Need To Know
↗
October 12, 2023
Via
Benzinga
Exxon Mobil To Rally Around 23%? Here Are 10 Other Analyst Forecasts For Thursday
↗
October 12, 2023
Cantor Fitzgerald cut Hyliion Holdings Corp. (NYSE: HYLN) price target from $2 to $1. Cantor Fitzgerald analyst Andres Sheppard downgraded the stock from Neutral to Underweight. Hyliion shares fell...
Via
Benzinga
Earnings Scheduled For November 13, 2023
↗
November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
Via
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
